ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
Frequently asked questions
What sector does ToolGen Inc. (199800) operate in?
ToolGen Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is ToolGen Inc. (199800) current stock price?
As of the latest data, ToolGen Inc. stock price is ₩27,850, with a previous close of ₩27,850.
What is ToolGen Inc. (199800) current market capitalization?
ToolGen Inc. market cap is approximately 272.15 billion.
What is ToolGen Inc. (199800) EBITDA?
ToolGen Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -6.28 billion.
Does ToolGen Inc. (199800) pay dividends?
No. ToolGen Inc. does not pay a dividend.
What is ToolGen Inc. (199800) beta (volatility) score?
ToolGen Inc. has a beta of 1.175, meaning its volatility is roughly in line with the market.